Biohaven To Report Third Quarter 2020 Financial Results And Recent Business Developments On November 9, 2020

NEW HAVEN, Conn., Oct. 30, 2020 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, will hold its…

Continue Reading

HEDGE accordingly